Global Microbiome Therapeutics Market Report By Type (FMT, Microbiome Drugs), Application (C. Difficile, Crohn’s Disease, Inflammatory Bowel Disease, Diabetes, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026
ID:VMR11210021
January 2020
Report Formats:

Microbiomes refers to the microorganisms residing in a particular environment, community or ecosystem. Basically, these microorganisms flourish in the areas like saliva, gastrointestinal tract (GT), etc. These microorganisms include bacteria, archaebacterial and fungi among many more. Microbiome Therapeutics refers to the development and advancement of therapies which interact with the gut microbiomes to improve the status of human health. The increasing number of population affected by inflammatory bowel diseases is the prime factor driving the microbiome therapeutics market.

As per Value Market Research, the Global Microbiome Therapeutics Market is expected to be worth USD 327.9 Million by 2024 with a CAGR of 45.7%.
 
FMT EMERGE AS THE LEADING TYPE SEGMENT
Fecal Microbiota Transplant (FMT) is widely used in microbiome therapeutics. FMT market is rapidly growing owing to its properties such as cost-effective, having low risk and highly effective treatment. The market for FMT has estimated to touch USD XX.X Million revenue by the end of 2024.
 
C. DIFFICILE EMERGES AS THE LARGEST APPLICATION OF MICROBIOME THERAPEUTICS
As per the study of Centers for Disease Control and Prevention (CDC), half of a million people are affected by C. difficile infection in the United States is majorly driving the segment growth. Further, the increasing number of death (approximately 29000 in the 30 days of initial diagnosis) caused life-threatening infection is again fueling the growth. It is estimated to reach USD XX.X Million revenue by the end of 2024.
 
NORTH AMERICA MARKET IS GAINING THE MOMENTUM
North America is accounted for the remarkable growth in the microbiome therapeutics market owing to the growing number of aging population. Additionally, the well-established research facilities along with the availability of advanced novel therapeutics are again fueling the regional growth. Further, the presence of key players helps North America to dominate the market. As a result, North America is expected to reach USD XX.X Million by the end of 2024.
 
PROMINENT PLAYERS IN THE GLOBAL MARKET
Enterome Bioscience, MaaT Pharma, MicroBiome Therapeutics LLC, OpenBiome, Rebiotix, Inc., Ritter Pharmaceuticals Inc., Second Genome, and Seres Therapeutics Inc. are the major players driving in the global microbiome therapeutics market.

As per this study, the Global Microbiome Therapeutics Market was valued at USD XX.X Million (by revenue) in 2019 and is anticipated to reach USD XXX.X Million by 2026 with a CAGR of XX.X%.
 
Microbiomes refers to the microorganisms residing in a particular environment, community or ecosystem. Microorganisms living in a particular ecosystem are also referred to as microbiota. Generally, these microorganisms flourish in the areas like saliva, gastrointestinal tract (GT), etc. These microorganisms include bacteria, archaebacteria, and fungi among many more. The health state of a person is highly dependent on such beneficial microbiomes. A healthy person houses a vast diversity of colonies of bacteria living together contributing to a healthier living of the person, and weigh about 3 pounds in an average adult. However, the lack of such diversity attracts numerous diseases.
 
Market Dynamics
 
Increasing demand for treatments with high efficiency along with the increase in a number of inflammatory bowel disease and diabetes is expected to drive the market demand. Technological advancements, high acceptance, and increasing awareness are further supporting the market growth. However, high cost due to complexities in the development process and a limited set of regulations may hamper the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of microbiome therapeutics.
 
Market Segmentation
 
The broad microbiome therapeutics market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Application Market Share 2019
 
Microbiome Therapeutics Market By Application
 
By Type

  • FMT
  • Microbiome Drugs
 
By Application
  • C. Difficile
  • Crohn’s Disease
  • Inflammatory Bowel Disease
  • Diabetes
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for microbiome therapeutics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Microbiome Therapeutics Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the microbiome therapeutics market includes Enterome Bioscience, MaaT Pharma, MicroBiome Therapeutics LLC, OpenBiome, Rebiotix, Inc., Ritter Pharmaceuticals Inc., Second Genome, and Seres Therapeutics Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
Major Company Players Market Share
 
Major Players of Microbiome Therapeutics Market
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Microbiome Therapeutics Market
       2.2. Global Microbiome Therapeutics Market Snapshot
 
3 . MICROBIOME THERAPEUTICS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Microbiome Therapeutics Market
       3.3. Market Restraints of Microbiome Therapeutics Market
       3.4. Opportunities of Microbiome Therapeutics Market
       3.5. Trends of Microbiome Therapeutics Market
       3.6. Porter’s Five Force Analysis of Microbiome Therapeutics Market
       3.7. Microbiome Therapeutics Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Microbiome Therapeutics Value Chain Analysis
       4.2. Microbiome Therapeutics Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Microbiome Therapeutics Raw Material Manufactures List
           4.2.3. Price Trend of Microbiome Therapeutics Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL MICROBIOME THERAPEUTICS MARKET ANALYSIS BY TYPE
       5.1 Overview by Type
       5.2 Global Microbiome Therapeutics Market Analysis by Type
       5.3 Market Analysis of FMT by Regions
       5.4 Market Analysis of Microbiome Drugs by Regions
 
6 . GLOBAL MICROBIOME THERAPEUTICS MARKET ANALYSIS BY APPLICATION
       6.1 Overview by Application
       6.2 Global Microbiome Therapeutics Market Analysis by Application
       6.3 Market Analysis of C. Difficile by Regions
       6.4 Market Analysis of Crohn’s Disease by Regions
       6.5 Market Analysis of Inflammatory Bowel Disease by Regions
       6.6 Market Analysis of Diabetes by Regions
       6.7 Market Analysis of Others by Regions
 
7 . GLOBAL MICROBIOME THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Microbiome Therapeutics Market Estimate by Market Segment
           7.3.3. North America Microbiome Therapeutics Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Microbiome Therapeutics Market Estimate by Market Segment
           7.4.3. Europe Microbiome Therapeutics Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Microbiome Therapeutics Market Estimate by Market Segment
           7.5.3. Asia Pacific Microbiome Therapeutics Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Microbiome Therapeutics Market Estimate by Market Segment
           7.6.3. Latin America Microbiome Therapeutics Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Microbiome Therapeutics Market Estimate by Market Segment
           7.7.3. Middle East & Africa Microbiome Therapeutics Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE MICROBIOME THERAPEUTICS COMPANIES
       8.1. Microbiome Therapeutics Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF MICROBIOME THERAPEUTICS INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Enterome Bioscience
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. MaaT Pharma
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. MicroBiome Therapeutics LLC
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. OpenBiome
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Rebiotix, Inc.
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Ritter Pharmaceuticals Inc.
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Second Genome
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Seres Therapeutics Inc.
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES

  •  Global Microbiome Therapeutics Market Snapshot
  •  Drivers of The Global Microbiome Therapeutics Market Impact Analysis
  •  Restraints of The Global Microbiome Therapeutics Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Global Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in FMT by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in Microbiome Drugs by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis by Application (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in C. Difficile by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in Crohn’s Disease by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in Inflammatory Bowel Disease by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in Diabetes by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in Others by Geography (USD MN)
  •  Global Microbiome Therapeutics Market by Geography (USD MN)
  •  North America Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  North America Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  North America Microbiome Therapeutics Market Estimate by Country (USD MN)
  •  United State Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  United State Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Rest of North America Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Rest of North America Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Europe Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Europe Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  United Kingdom Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  United Kingdom Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  France Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  France Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Germany Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Germany Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Rest of Europe Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Rest of Europe Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Asia Pacific Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Asia Pacific Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Asia Pacific Microbiome Therapeutics Market Estimate by Country (USD MN)
  •  China Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  China Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Japan Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Japan Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  India Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  India Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Rest of Asia Pacific Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Rest of Asia Pacific Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Latin America Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Latin America Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Latin America Microbiome Therapeutics Market Estimate by Country (USD MN)
  •  Brazil Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Brazil Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Rest of Latin America Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Rest of Latin America Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Middle East & Africa Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Middle East & Africa Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Middle East & Africa Microbiome Therapeutics Market Estimate by Country (USD MN)
  •  Middle East Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Middle East Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Africa Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Africa Microbiome Therapeutics Market Estimate by Application (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis, 2019
 
 LIST OF FIGURES
  •  Research Scope of Microbiome Therapeutics Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Microbiome Therapeutics Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Microbiome Therapeutics Market Analysis by Type (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in FMT by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in Microbiome Drugs by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis by Application (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in C. Difficile by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in Crohn’s Disease by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in Inflammatory Bowel Disease by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in Diabetes by Geography (USD MN)
  •  Global Microbiome Therapeutics Market Analysis in Others by Geography (USD MN)
  •  Latin America Microbiome Therapeutics Market by Revenue
  •  Middle East & Africa Microbiome Therapeutics Market by Revenue
  •  Recent Development in Microbiome Therapeutics Industry
  •  Company Market Share Analysis, 2019        

 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials